Reprieve for Merck’s vorapaxar
January 16, 2014Sales and Marketing FDA, Merck, heart, vorapaxar
An FDA committee has voted that Merck’s troubled heart drug vorapaxar should be approved by the US regulator. The advisory …
Heptares appoints Tim Tasker as chief medical officer


January 16, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Heptares, tim tasker
Drug development firm Heptares Therapeutics has appointed Dr Tim Tasker as its chief medical officer (CMO) and VP of Development. …
Doctor-pharma relationships ‘can’t be trusted’
January 16, 2014Sales and Marketing BMJ, NHS, doctors, pharma
A US doctor has warned that patients will lose trust in healthcare professionals if they do not disclose the extent …
Plastic surgery app for girls pulled from iTunes
January 15, 2014Medical Communications Apple, app, digital, itunes, surgery
Experts have welcomed a decision to axe an app that encourages young girls to have plastic surgery saying that it …
GSK has Tafinlar ‘breakthrough’
January 15, 2014Sales and Marketing Cancer, FDA, GSK, NSCLC, Tafinlar
GlaxoSmithKline is on a roll, with its cancer drug Tafinlar given breakthrough therapy designation by the FDA in lung cancer …
AZ bullish on its future – but analysts wary
January 15, 2014Sales and Marketing AstraZeneca, Roche, analysts, jp morgan
AstraZeneca is combating fears over its long-term future by assuring investors that it has the pipeline and the tenacity to …
ICON hires Dr Steve Cutler as chief operating officer
January 15, 2014Manufacturing and Production, Research and Development, Sales and Marketing ICON, cutler
Clinical research organisation ICON has appointed Dr Steve Cutler to the newly created position of chief operating officer (COO).
UK cancer figures rise
January 15, 2014Research and Development, Sales and Marketing Cancer, England, NHS, research uk
More people are being diagnosed with cancer than ever before, according to figures from Cancer Research UK – as an …
Bayer and Regeneron to co-develop wet AMD antibody
January 14, 2014Research and Development, Sales and Marketing Bayer, Eylea, Regeneron, pdgfr-beta, wet AMD
Bayer and Regeneron are co-developing an antibody to the Platelet Derived Growth Factor Receptor Beta (PDGFR-beta) as a combination therapy …
FDA approves GSK cancer combo
January 14, 2014Research and Development, Sales and Marketing FDA, GSK, Tafinlar, mekinist
US regulators have shown the green light to a combination of two GlaxoSmithKline skin cancer drugs, Mekinist and Tafinlar, to …
Sanofi signs new genetics deal with Isarna
January 14, 2014Manufacturing and Production, Research and Development, Sales and Marketing DNA, RNA, Sanofi, aso, isarna
Sanofi has agreed to produce genetic compounds developed by German biotech Isarna Therepeutics to accelerate their progress to the clinical …
Incyte names former Novartis president as its chief executive
January 14, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Incyte, Novartis, hoppenot
Biopharma firm Incyte has announced that the former president of Novartis Oncology has been named as its president and chief …
GSK makes imaging deal
January 14, 2014Manufacturing and Production, Sales and Marketing 3D, GSK, imaging, npl
GlaxoSmithKline has signed a deal with the National Physical Laboratory (NPL) to develop an imaging system which can show for …
New managing director for Boehringer Ingelheim UK
January 13, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim, krumins
Zinta Krumins has been appointed as the managing director of Boehringer Ingelheim UK & Ireland. The appointment will present a …
NICE: Daily Mail ‘misled’ readers
January 13, 2014Sales and Marketing Dillon, NHS, NICE, mail
UK drugs watchdog NICE has hit back at an article in the Daily Mail headlined “Champagne perks of NHS drug …
Sanofi pays $700m to expand rare disease portfolio
January 13, 2014Research and Development, Sales and Marketing Alnylam, Sanofi, rare sidease
Sanofi and Alnylam have announced the expansion of their 2012 agreement to develop and sell treatments for rare genetic diseases. …
Thought leader mapping: do we need a radical rethink?
January 13, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Havas, bartley, marketing, sales, thought leader
The effectiveness of healthcare communications is often more reliant on who’s delivering the message than the content of the message …
New chief executive for Quanta Fluid Solutions
January 13, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing milad, quanta
Medical devices firm Quanta Fluid Solutions has announced the appointment of John Milad as chief executive. Milad’s career spans 20 …
Treat patients ‘more holistically’
January 13, 2014Sales and Marketing Hunt, Mid Staffs, NHS, new year
UK health secretary Jeremy Hunt has spoken of the challenges faced by the NHS in a New Year message to …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
